{
    "cord_uid": "m6abyuvx",
    "source_x": "PMC",
    "pmcid": "PMC3524174",
    "divid": "32",
    "text": "In conclusion, our findings demonstrated that rVV-N25 is a promising candidate for an HCV vaccine therapy. Additionally, the findings of this study indicate that rVV-N25 immunization can be used for prevention of HCV infection and as an antiviral therapy against ongoing HCV infection. ",
    "project": "cdlai_CORD-19",
    "denotations": []
}